Print this page    •   Back to Web version of article

U.S. News
National Institutes of Health Gives Vanderbilt University $1.4 Million for HIV Vaccine Research

February 19, 2014

This article was reported by Ledger-Enquirer.

The Ledger-Enquirer reported that Tennessee's Vanderbilt University received a $1.4 million grant from the US National Institutes of Health to continue its research in HIV treatment and development of an HIV vaccine. While advances in HIV medications have allowed people with HIV to live longer, healthier lives, Vanderbilt doctors say better treatments will curb health threats they face, including increased risk of stroke, heart attack, and other fatal diseases. A vaccine to prevent anyone from becoming infected with HIV is "imperative" said the doctors. Researchers still are trying to figure out why only 30 percent of people in a recent vaccine trial in Thailand seemed to be protected from HIV, while others were not.

Back to other news for February 2014

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.